. FDA removes clinical trial hold on Novavax COVID-flu combo and flu vaccines - IOPAC Press "Enter" to skip to content

WHO adds LC16m8 mpox vaccine to Emergency Use Listing
- All WHO news
The World Health Organization (WHO) has granted Emergency Use Listing (EUL) for the LC16m8 mpox vaccine, making it the second...
WHO Investment Round: culminating moment at G20 Summit as leaders pledge
- All WHO news
The first-ever Investment Round of the World Health Organization (WHO) reached a culminating moment during the G20 Leaders' Summit today in...
WHO and partners rally cervical cancer elimination efforts
- All WHO news
As world leaders arrive in Rio de Janeiro, Brazil, for the G20 Summit this weekend, the city’s iconic Christ the...

The right to health
- WHO Director-General speeches
Excellencies, ladies and gentlemen, Good afternoon, and thank you for having me. It’s a real honour to be with you...
Closing address at High-Level Action Day, First WHO Global Conference on Air Pollution and Health
- WHO Director-General speeches
Every human being is entitled to breathe clean air. It’s a human right. We are honoured to have the Human...
Opening address at the First WHO Global Conference on Air Pollution and Health
- WHO Director-General speeches
Excellency, second Lady Hajia Samira Bawumia of Ghana, my colleague colleague Dr Taalas, Secretary General of WMO and my sister...

FDA removes clinical trial hold on Novavax COVID-flu combo and flu vaccines

By iopac on November 12, 2024

The adverse event in the earlier clinical trial involved amyotrophic lateral sclerosis, which wasn’t related to vaccination.

Published in COVID-19

iopac